Packaging & Labeling: Innovation and applications in pharma packaging, security, and identification technology - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Packaging & Labeling
Materials for packaging pharmaceuticals, sustainability, and green materials. Anticounterfeiting measures such as RFID, 2D barcode, & holograms for track-and-trace, e-pedigree. Digital and conventional label printing.

Adopting Serialization

August 2, 2010

Pharmaceutical Technology

Serialized product codes serve as the foundation of ePedigree records and product traceability.

Is Your Packaging Line Operating To Full Capacity?

August 1, 2010

Pharmaceutical Technology Europe

Overall Equipment Effectiveness has been shown to identify the root cause of inefficiencies.

Week of July 26, 2010: Company and People Notes: Merck and Sinopharm Sign Agreement; Agilent Appoints CFO; And More.

July 29, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Merck and Sinopharm Sign Agreement; Agilent Appoints CFO; And More.

Week of July 19, 2010: Company and People Notes: Pfizer Ends Second Tanezumab Clinical Program; Catalent VP Joins USP Panel; And More.

July 22, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Pfizer Ends Second Tanezumab Clinical Program; Catalent VP Joins USP Panel; And More.

Week of July 12, 2010: Company and People Notes: Xcelience and Penn Form Joint Venture; Almac Appoints QA Director; And More.

July 15, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Xcelience and Penn Form Joint Venture; Almac Appoints QA Director; And More.

Week of July 5, 2010: Company and People Notes: Eli Lilly to Acquire Alnara Pharmaceuticals; Exelixis CEO Leaves for Biogen Idec; And More.

July 8, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Eli Lilly to Acquire Alnara Pharmaceuticals; Exelixis CEO Leaves for Biogen Idec; And More.

A Word to the Unwise

July 2, 2010

Pharmaceutical Technology

After a spate of industrial disasters, the public seeks greater oversight of corporations—so does FDA.

Overt versus covert technologies

July 1, 2010

Pharmaceutical Technology Europe

Despite the development of covert security technologies, overt solutions are still very important when it comes to product security strategies.

EU anti-counterfeiting legislation on its way

July 1, 2010

Pharmaceutical Technology Europe

With the increasing financial and technical means of counterfeiters, the number of counterfeit pharmaceuticals in the supply chain is growing at an alarming rate.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Click here